$31.92 B
Share price
Change (1 day)
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Cash on Hand

Cash on Hand as of March 2024 : $1.07 B

According to Biogen's latest financial reports the company has $1.07 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Biogen - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$1.04 B-78.54%
2022-12-31$4.89 B28.67%
2021-12-31$3.80 B45.68%
2020-12-31$2.61 B-41.69%
2019-12-31$4.47 B26.51%
2018-12-31$3.53 B-4.09%
2017-12-31$3.68 B-24.64%
2016-12-31$4.89 B42.78%
2015-12-31$3.42 B85.79%
2014-12-31$1.84 B50.92%
2013-12-31$1.22 B-28.32%
2012-12-31$1.70 B0.89%
2011-12-31$1.69 B39.98%
2010-12-31$1.20 B-4.43%
2009-12-31$1.26 B-5.83%
2008-12-31$1.34 B13.39%
2007-12-31$1.18 B31.11%
2006-12-31$0.90 B6.1%
2005-12-31$0.85 B306.19%
2004-12-31$0.20 B-33.48%
2003-12-31$0.31 B-60.03%
2002-12-31$0.78 B-1.29%
2001-12-31$0.79 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$26.21 B 2,340.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.92 B 1,010.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.06 B 1,581.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.70 B 803.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.92 B 824.06%๐Ÿ‡ซ๐Ÿ‡ท France
$4.71 B 339.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.10 B 3.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.36 M-99.13%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.89 B-16.87%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$1.64 B 53.17%๐Ÿ‡บ๐Ÿ‡ธ USA